人类组织因子途径抑制物（TFPI）基因启动子区域的C-399T多态性不会改变血浆TFPI抗原水平，也不会导致静脉血栓形成。 - Suppr | 超能文献

C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis.

作者信息

Miyata T, Sakata T, Kumeda K, Uchida K, Tsushima M, Fujimura H, Kawasaki T, Kato H

出版信息

Thromb Haemost. 1998 Aug;80(2):345-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis.人类组织因子途径抑制物（TFPI）基因启动子区域的C-399T多态性不会改变血浆TFPI抗原水平，也不会导致静脉血栓形成。

Thromb Haemost. 1998 Aug;80(2):345-6.

2

Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.组织因子途径抑制物基因中T-287C多态性分析及启动子中一个阻遏元件的鉴定。

Thromb Res. 2008;121(6):813-9. doi: 10.1016/j.thromres.2007.08.012. Epub 2007 Oct 10.

3

Functional characterization of polymorphisms in the human TFPI gene.鉴定人组织因子途径抑制物（TFPI）基因多态性的功能特征。

Biochem Biophys Res Commun. 2010 Jun 18;397(1):106-11. doi: 10.1016/j.bbrc.2010.05.078. Epub 2010 May 16.

4

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.有和无静脉血栓形成病史的女性组织因子途径抑制剂多态性及绝经后激素治疗的影响

Blood Coagul Fibrinolysis. 2010 Sep;21(6):516-21. doi: 10.1097/MBC.0b013e32833a06cd.

5

Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.组织因子途径抑制物基因多态性与抗磷脂综合征及凝血因子V Leiden携带者的静脉血栓栓塞相关。

Blood Coagul Fibrinolysis. 2007 Sep;18(6):559-64. doi: 10.1097/MBC.0b013e3281eec977.

6

A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1489-92. doi: 10.1161/01.ATV.0000166602.04711.2e. Epub 2005 Apr 21.

7

The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.

Thromb Haemost. 1999 Jul;82(1):1-5.

8

Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.患脑膜炎球菌病儿童血浆和尿液中的组织因子途径抑制剂（TFPI）水平

Thromb Haemost. 2001 Feb;85(2):240-4.

9

The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.组织因子途径抑制物（TFPI）基因第7内含子中的-33T→C多态性影响静脉血栓栓塞风险，独立于因子V莱顿突变和凝血酶原突变。

Thromb Haemost. 2002 Aug;88(2):195-9.

10

A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.

Thromb Haemost. 2000 Aug;84(2):244-9.

引用本文的文献

1

Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study.中老年人群中凝血调节因子组织因子途径抑制物的基因变异与静脉血栓栓塞症：一项基于人群的队列研究。

Res Pract Thromb Haemost. 2022 Nov 9;6(7):e12842. doi: 10.1002/rth2.12842. eCollection 2022 Oct.

2

Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis.组织因子途径抑制物（TFPI）基因多态性rs8176592、rs10931292和rs10153820与静脉血栓形成的相关性：一项荟萃分析。

Medicine (Baltimore). 2019 Mar;98(12):e14978. doi: 10.1097/MD.0000000000014978.

3

Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells.

Mol Cell Biochem. 2006 Feb;283(1-2):31-8. doi: 10.1007/s11010-006-2267-9.